The Vitamins

The Vitamins

Volumn , Issue , 2012, Pages

  Combs, Gerald ^a  

^a Department of Obstetrics Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85013807415     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/C2009-0-63016-6     Document Type: Book

References (557)

1. Baron J.H. Sailor's scurvy before and after James Lind - a reassessment. Nutr. Rev. 2009, 67:315.
2. Carpenter K.J. The History of Scurvy and Vitamin C 1986, Cambridge University Press, Cambridge, MA, (288 pp.).
3. Carpenter K.J. Beriberi, White Rice and Vitamin B: A Disease, a Cause, and a Cure 2000, University of California Press, Los Angeles, CA, (282 pp.).
4. Carpenter K.J. A short history of nutritional science: Part 1 (1785-1885). J. Nutr. 2003, 133:638.
5. Carpenter K.J. A short history of nutritional science: Part 2 (1885-1912). J. Nutr. 2003, 133:975.
6. Carpenter K.J. A short history of nutritional science: Part 3 (1912- 1944). J. Nutr. 2003, 133:3023.
7. Carpenter K.J. A short history of nutritional science: Part 4 (1945-1985). J. Nutr. 2003, 133:3331.
8. Györgi P. Early experiences with riboflavin - a retrospect. Nutr. Rev. 1954, 12:97.
9. Harris L.J. Vitamins in Theory and Practice 1955, Cambridge University Press, Cambridge, MA, pp. 1-39.
10. Lepkovsky S. Early experiences with pyridoxine - a retrospect. Nutr. Rev. 1954, 12:257.
11. Olson J.A. Vitamins: The tortuous path from needs to fantasies. J. Nutr. 1994, 124:1771S-1776S.
12. Roe D.A. A Plague of Corn: The Social History of Pellagra 1973, Cornell University Press, Ithaca, NY.
13. Sebrell W.H. History of pellagra. Fed. Proc. 1981, 40:1520.
14. Sommer A. Vitamin A deficiency and clinical disease: An historical overview. J. Nutr. 2008, 138:1835.
15. Wald G. Molecular basis of visual excitation. Science 1968, 162:230-239.
16. Wolf G. The discovery of the visual function of vitamin A. J. Nutr. 2001, 131:1647-1650.
17. Anonymous Nomenclature policy: Generic descriptors and trivial names for vitamins and related compounds. J. Nutr. 1987, 120:12-19.
18. Ball G.F.M. Bioavailability and Analysis of Vitamins in Foods 1998, Chapman & Hall, New York, NY, 569 pp.
19. Eitenmiller R.R., Landen W.O. Vitamin Analysis for the Health and Food Sciences 1999, CRC Press, New York, NY, 518 pp.
20. Handbook of Vitamins 2007, CRC Press, New York, NY, 593 pp. fourth ed. J. Zempleni, R.B. Rucker, D.B. McCormick, J.W. Suttie (Eds.).
21. Marks J. The Vitamins in Health and Disease 1968, Churchill, London, UK.
22. Handbook of Vitamins 2007, CRC Press, New York, NY, (593 pp.). fourth ed. J. Zempleni, R.B. Rucker, D.B. McCormick, J.W. Suttie (Eds.).
23. ACC/SCN Consultative Group, 1994. Controlling vitamin A deficiency. Nutrition policy paper No. 14. In: Gillespie, S., Mason, J.B. (Eds.), United Nations Administrative Committee of Coordination - Subcommittee on Nutrition, New York, NY, 81 pp.
24. Azais-Braesco V., Pascal G. Vitamin A in pregnancy: Requirements and safety limits. Am. J. Clin. Nutr. 2000, 71:1325S-1333S.
25. Bellemère G., Stamatas G.N., Bruère V., et al. Antiaging action of retinol: From molecular to clinical. Skin Pharmacol. Physiol. 2009, 22:200-209.
26. Bendich A., Langseth L. Safety of vitamin A. Am. J. Clin. Nutr. 1989, 49:358-371.
27. Bloem M.W. Interdependence of vitamin A and iron: An important association for programmes of anemia control. Proc. Nutr. Soc. 1995, 54:501-508.
28. Campo-Paysaa F., Marlétaz F., Laudet V., Schubert M. Retinoic acid signaling in development: Tissue-specific functions and evolutionary origins. Genesis 2008, 46:640-656.
29. Casetenmiller J.J.M., West C.E. Bioavailability and bioconversion of carotenoids. Ann. Rev. Nutr. 1998, 18:19-38.
30. Chroni E., Monastrili A., Tsambo D. Neuromuscular adverse effects associated with systemic retinoid dermatotherapy: Monitoring and treatment algorithm for clinicians. Drug Saf. 2010, 33:25-34.
31. Congdon N.G., West K.P. Physiological indicators of vitamin A status. J. Nutr. 2002, 132:2889S-2894S.
32. Duester G. Retinoic acid synthesis and signaling during early organogenesis. Cell 2008, 134:921-931.
33. Duriancik D.M., Lackey D.E., Hoag K.A. Vitamin A as a regulator of antigen presenting-molecules. J. Nutr. 2010, 140:1395-1399.
34. Futoryan T., Gilchrest B.A. Retinoids and the skin. Nutr. Rev. 1994, 52:299-310.
35. Graham T.E., Yang Q., Blüher M., et al. β-Carotene is an important vitamin A source for humans. J. Nutr. 2010, 140:2268S-2285S.
36. Harrison E.H. Mechanisms of digestion and absorption of dietary vitamin A. Ann. Rev. Nutr. 2005, 25:87-103.
37. Latham M. The great vitamin A fiasco. J. World Pub. Health Nutr. Assoc. 2010, 1:12-24.
38. Leitz G., Lange J., Rimbach G. Molecular and dietary regulation of β,β-carotene 15,15'-monooxygenase 1 (BCMO1). Arch. Biochem. Biophys. 2010, 502:8-16.
39. Li E., Norris A.W. Structure/function of cytosolic vitamin A-binding proteins. Annu. Rev. Nutr. 1996, 16:205-234.
40. Libien J., Blaner W.S. Retinol and retinol-binding protein in cerebrospinal fluid: Can vitamin A take the "idiopathic" out of idiopathic intracranial hypertension?. J. Neuro-Ophthalmol. 2007, 4:253-257.
41. Lobo G.P., Hessel S., Eichinger A., et al. ISX is a retinoic acid-sensitive gatekeeper that controls intestinal β-carotene absorption and vitamin A production. FASEB J. 2010, 24:1656-1666.
42. Mason J.B., Lotfi M., Dalmiya N., et al. The Micronutrient Report: Current Progress in the Control of Vitamin A, Iodine and Iron Deficiencies 2001, The Micronutrient Initiative, Ottawa, 116 pp.
43. McClaren D.S., Frigg M. Sight and Life Manual on Vitamin A Deficiency Disorders (VADD) 1997, Task Force for Sight and Life, Basel, 138 pp.
44. Mora J.R., von Andrian U.H. Role of retinoic acid in the imprinting of gut-homing IgA-secreting cells. Semin. Immunol. 2009, 21:28-35.
45. Noy N. Between death and survival: Retinoic acid in regulation of apotosis. Ann. Rev. Nutr. 2010, 30:201-217.
46. Ong D.E. Cellular transport and metabolism of vitamin A: Roles of the cellular retinol-binding proteins. Nutr. Rev. 1994, 52:S24-S31.
47. Penniston K.L., Tanumihardjo S.A. The acute and chronic toxic effects of vitamin A. Am. J. Clin. Nutr. 2006, 83:191-201.
48. Pino-Lago K., Benson M.J., Noelle R.J. Retinoic acid in the immune system. Ann. NY Acad. Sci. 2008, 1143:170-187.
49. Ramakrishnan U., Darnton-Hill I. Assessment and control of vitamin A deficiency disorders. J. Nutr. 2002, 132:2947S-2953S.
50. Reifen R. Vitamin A as an anti-inflammatory agent. Proc. Nutr. Soc. 2002, 61:397-400.
51. Ribaya-Mercado J.D., Blumberg J.B. Vitamin A: Is it a risk factor for osteoporosis and bone fracture?. Nutr. Rev. 2007, 65:425-438.
52. Ross C., Harrison E.H. Vitamin A: Nutritional aspects of retinoids and carotenoids. Handbook of Vitamins 2007, 1-40. CRC Press, New York, NY. fourth ed. J. Zempleni, R.B. Rucker, D.B. McCormick, J.W. Suttie (Eds.).
53. Ross C., Chen Q., Ma Y. Augmentation of antibody responses by retinoic acid and costimulatory molecules. Semin Immunol. 2009, 21:42-50.
54. Solomons N.W. Plant sources of pro-vitamin A and human nutriture. Nutr. Rev. 1993, 51:199-204.
55. Solomons N.W., Bulux J. Present Knowledge in Nutrition. Vitamin A 2006, vol I:157-183. ILSI Press, Washington, DC. ninth ed.
56. Sommer A. Vitamin A deficiency and clinical disease: An historical overview. J. Nutr. 2008, 138:1835-1839.
57. Sommer A., West K.P., Olson J.A., Ross C.A. Vitamin A Deficiency: Health, Survival, and Vision 1996, Oxford University Press, New York, NY, (452 pp.).
58. Soprano D.R., Soprano K.J. Retinoids as teratogens. Annu. Rev. Nutr. 1995, 15:111-132.
59. Soprano D.R., Qin P., Soprano K.J. Retinoic acid receptors and cancers. Annu. Rev. Nutr. 2004, 24:201-221.
60. Tang G. Bioconversion of dietary provitamin A carotenoids to vitamin A in humans. Am. J. Nutr. 2010, 91:1468S-1473S.
61. Thatcher J.E., Isoheranen N. The role of CYP26 enzymes in retinoic acid clearance. Expert. Opin. Drug Metab. Toxicol. 2009, 5:875-886.
62. Underwood B.A. Teratogenecity of vitamin A. Elevated Dosages of Vitamins: Benefits and Hazards 1989, 42-55. Hans Huber, Berlin. P. Walter, G. Brubacher, H. Stähelin (Eds.).
63. Underwood B.A. Maternal vitamin A status and its importance in infancy and early childhood. Am. J. Clin. Nutr. 1994, 59:517S-524S.
64. Van Poppel G., Goldbohm R.A. Epidemiologic evidence for β-carotene and cancer prevention. Am. J. Clin. Nutr. 1995, 62:1393S-1402S.
65. Villamour E., Fawzi W.W. Effects of vitamin A supplementation on immune responses and correlations with clinical outcomes. Clin. Micro. Rev. 2005, 18:446-464.
66. Wang Z., Yin S., Zhao X., et al. β-Carotene-vitamin A equivalence in Chinese adults assessed by an isotope dilution technique. Br. J. Nutr. 2004, 91:121-131.
67. West K.P. Extent of vitamin A deficiency among preschool children and women of reproductive age. J. Nutr. 2002, 132:2857S-2866S.
68. Willett W.C., Hunter D.J. Vitamin A and cancers of the breast, large bowel and prostate: Epidemiologic evidence. Nutr. Rev. 1994, 52:S53-S59.
69. Wolf G. The visual cycle of the cone photoreceptors of the retina. Nutr. Rev. 2004, 62:283-286.
70. Wolf G. Serum retinol-binding protein: A link between obesity, insulin resistance, and type 2 diabetes. Nutr. Rev. 2007, 65:251-256.
71. World Health Organization. (2009). Global Prevalence of Vitamin A Deficiency in Populations at Risk 1995-2005. WHO Global Database on Vitamin A Deficiency, Geneva, World Health Organization. <> (accessed 25.02.11). http://www.who.int/vmnis/.
72. Yeum K.J., Russell R.M. Carotenoid bioavailability and bioconversion. Ann. Rev. Nutr. 2002, 22:483-504.
73. Ziouzenkova O., Plutzky J. Retinoid metabolism and nuclear receptor responses: New insights into coordinated regulation of the PPAR-RXR complex. FEBS Letts 2008, 582:32-38.
74. Aloia J.F. African Americans, 25-hydroxyvitamin D, and osteoporosis: A paradox. Am. J. Clin. Nutr. 2008, 88:545S-550S.
75. Angelo G., Wood R.J. Novel intercellular proteins associated with cellular vitamin D action. Nutr. Rev. 2002, 60:209-214.
76. Annweiler C., Montero-Odasso M., Schott A.M., et al. Fall prevention and vitamin D in the elderly: An overview of the key role of the non-bone effects. J. NeuroEngin. Rehab. 2010, 7:50-63.
77. Baeke F., Takiishi T., Korf H., et al. Vitamin D: Modulator of the immune system. Curr. Opin. Pharmacol. 2010, 10:482-496.
78. Bikke D.D. Vitamin D and the skin. J. Bone Miner. Metab. 2010, 28:117-130.
79. Bikke D.D. Vitamin D: Newly discovered actions require consideration of physiologic requirements. Trends Endocrinol. Metab. 2010, 21:375-384.
80. Bischoff-Ferrari H.A., Giovannucci E., Willett W.C., et al. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple outcomes. Am. J. Clin. Nutr. 2006, 84:18-28.
81. Bonner F. Mechanisms of intestinal calcium absorption. J. Cell. Biochem. 2003, 88:387-393.
82. Borradale D., Kimlin M. Vitamin D in health and disease: An insight into traditional functions and new roles for the "sunshine vitamin.". Nutr. Res. Rev 2009, 22:118-136.
83. Bouillon R., Van Cromphaut S., Carmeliet G. Intestinal calcium absorption: Molecular vitamin D mediate mechanisms. J. Cell. Biochem. 2003, 88:332-339.
84. Campbell F.C., Xu H., El-Tanani M., et al. The yin and yang of vitamin D receptor (VDR) signaling in neoplastic progression: Operational networks and tissue-specific growth control. Biochem. Pharmacol. 2010, 79:1-9.
85. Christakos S., Barletta F., Huening M., et al. Vitamin D target proteins: Function and regulation. J. Cell. Biochem. 2003, 88:238-244.
86. Crannery A., Weiler H.A., O'Donnel S., Puil L. Summary of evidence-based review of vitamin D efficacy and safety in relation to bone health. Am. J. Clin. Nutr. 2008, 88:513S-519S.
87. Dawson-Hughes B. Calcium and vitamin D for bone health in adults. Nutrition and Bone Health 2004, 197-210. Humana Press, Totowa, NJ. M.F. Holick, B. Dawson-Hughes (Eds.).
88. DeLuca H.F. Evolution of our understanding of vitamin D. Nutr. Rev. 2008, 66:S73-S87.
89. Dombrowski Y., Peric M., Koglin S., et al. Control of cutaneous antimicrobial peptides by vitamin D3. Arch. Dermatol. Res. 2010, 302:401-408.
90. Dror D.K., Allen L.H. Vitamin D inadequacy in pregancy: Biology, outcomes, and interventions. Nutr. Rev. 2010, 68:465-477.
91. Eyles D.W., Feron F., Cui X., et al. Psychoneuroendocrinology 2009, 345:S247-S257.
92. Vitamin D 2006, vols I and II. Elsevier, New York, NY. second ed.
93. Fleet J.C. Rapid, membrane-initiated actions of 1,25-dihydroxyvitamin D: What are they and what do they mean?. J. Nutr. 2004, 134:3215-3218.
94. Flores M. A role of vitamin D in low-intensity chronic inflammation and insulin resistance in type 2 diabetes?. Nutr. Res. Rev. 2005, 18:175-182.
95. Garland C.F., Garland F.C., Gorham E.D., et al. The role of vitamin D in cancer prevention. Am. J. Pub. Health 2006, 96:252-261.
96. Grant W.B., Holick M.F. Benefits and requirements of vitamin D for optimal health: A review. Alt. Med. Rev. 2005, 10:94-111.
97. Hamilton B. Vitamin D and human skeletal muscle. Scand. J. Med. Sci. Sports 2010, 20:182-190.
98. Harris D.M., Go V.L. Vitamin D and colon carcinogenesis. J. Nutr. 2004, 134:3463S-3471S.
99. Hathcock J.N., Shao A., Vieth R., Heaney R. Risk assessment for vitamin D. Am. J. Clin. Nutr. 2007, 85:6-18.
100. Hayes D.P. Vitamin D and aging. Biogerontology 2010, 11:1-16.
101. Heaney R.P. Long-latency deficiency disease: Insights into calcium and vitamin D. Am. J. Clin. Nutr. 2003, 78:912-919.
102. Hoenderop J.G.J., Nilius B., Bindels R.J.M. Molecular mechanism of active Ca2+ reabsorption in the distal nephron. Ann. Rev. Physiol. 2002, 64:529-549.
103. Holick M.F. Vitamin D: Its role in cancer prevention and treatment. Progr. Biophys. Mol. Biol. 2006, 92:49-59.
104. Holick M.F. Vitamin D: A D-lightful health perspective. Nutr. Rev. 2008, 66:S182-S194.
105. Holick M.F. The vitamin D deficiency pandemic and consequences for nonskeletal health: Mechanism of action. Mol. Asp. Med. 2008, 29:361-368.
106. Holick M.F. Vitamin D: Extraskeletal health. Endocrinol. Metabol. Clin. North Am. 2009, 39:381-400.
107. Vitamin D: Physiology, Molecular Biology, and Clinical Applications 2010, Humana Press, New York, NY, 1155 pp. second ed. M.F. Holick (Ed.).
108. Institute of Medicine Dietary Reference Intakes: Calcium. Vitamin D 2011, National Academy Press, Washington, DC, 1115 pp.
109. Jones G. Pharmacokinetics of vitamin D toxicity. Am. J. Clin. Nutr. 2008, 88:582S-586S.
110. Kamen D.L., Tangpricha V. Vitamin D and molecular actions on the immune system: Modulation of innate and autoimmunity. J. Mol. Med. 2010, 88:441-450.
111. Lee J.H., O'Keefe J.H., Bell D., et al. Vitamin D deficiency: An important, common, and easily treatable cardiovascular risk factor?. J. Am. Coll. Cardiol. 2008, 52:1949-1956.
112. Levine A., Li Y.C. Vitamin D and its analogues: Do they protect against cardiovascular disease in patients with kidney disease?. Kidney Intl 2005, 68:1973-1981.
113. Lou Y.R., Qiao S., Talonpoika R., et al. The role of vitamin D3 metabolism in prostate cancer. J. Steroid Biochem. Mol. Biol 2004, 92:317-325.
114. Mathieu C., Gysemans C., Giulietti A., Bouillon R. Vitamin D and diabetes. Diabetologia 2005, 48:1247-1257.
115. Maxwell C.S., Wood R.J. Update on vitamin D and type 2 diabetes. Nutr. Rev. 2011, 69:291-295.
116. Maxwell J.D. Seasonal variation in vitamin D. Proc. Nutr. Soc. 1994, 53:533-543.
117. Mizwicki M.T., Norman A.W. The vitamin D sterol-vitamin D receptor ensemble model offers unique insights into both genomic and rapid-response vitamin D signaling. Sci. Signal. 2009, 2:1-14.
118. Montaro-Odasso M., Duque G. Vitamin D in the aging musculoskeletal system: An authentic strength preserving hormone. Mol. Aspects Med. 2005, 26:203-219.
119. Nagpal S., Na S., Rathnachalam R. Noncalcemic actions of vitamin D receptor ligands. Endocrinol. Rev. 2005, 26:662-687.
120. Norman A.W. A vitamin D nutritional cornucopia: New insights concerning serum 25-hydroxyvitamin D status of the US population. Am. J. Clin. Nutr. 2008, 88:1455-1456.
121. Norman A.W., Bouillon R. Vitamin D nutritional policy needs a vision for the future. Exp. Biol Med. 2010, 235:1034-1045.
122. Norman A.W., Henry H.L. Vitamin D. Present Knowledge in Nutrition 2006, vol. I:198-210. ILSI Press, Washington, DC. ninth ed.
123. Norman A.W., Henry H.L. Vitamin D. Handbook of Vitamins 2007, 41-109. CRC Press, New York, NY. fourth ed. J. Zempleni, R.B. Rucker, D.B. McCormick, J.W. Suttie (Eds.).
124. Omdahl J.L., Morris H.A., May B.K. Hydroxylase enzymes of the vitamin D pathway: Expression, function and regulation. Ann. Rev. Nutr. 2002, 22:139-166.
125. Peterlik M., Boonen S., Cross H.S., Lamberg-Allardt C. Vitamin D and calcium insufficiency-related chronic diseases: An emerging world-wide public health problem. Intl. J. Environ. Res. Public Health 2009, 6:2585-2607.
126. Posner G. Low-calcemic vitamin D analogs (deltanoids) for human cancer prevention. J. Nutr. 2002, 132:3802S-3803S.
127. Prentice A. Vitamin D deficiency: A global perspective. Nutr. Rev. 2008, 66:S153-S164.
128. Rojas-Rivera J., De La Piedra C., Ramos A., et al. The expanding spectrum of biological actions of vitamin D. Nephrol. Dial. Transplant. 2010, 25:2850-2865.
129. Samuel S., Sitrin M.D. Vitamin D's role in cell proliferatioin and differentiation. Nutr. Rev. 2008, 66:S116-S124.
130. Schwartz G.G. Vitamin D and the epidemiology of prostate cancer. Semin. Dial. 2005, 18:276-289.
131. Sergeev I.N. Calcium signaling in cancer and vitamin D. J. Steroid Biochem. Mol. Biol. 2005, 97:145-151.
132. Shaffer P.L., Gewith D.T. Vitamin D receptor-DNA interactions. Vitam. Horm. 2004, 68:257-273.
133. Solomon A.J., Whitham R.H. Multiple sclerosis and vitamin D: A review and recommendations. Curr. Neurol. Neurosci. Rep. 2010, 10:389-396.
134. Standing Committee on the Scientific Evaluation of Dietary Reference Intakes Dietary Reference Intakes for Calcium, Phophorus, Magnesium, Vitamin D and Fluoride 1997, National Academy Press, Washington, DC, pp. 250-287.
135. Straube S., Moore R.A., Derry S., McQuay H.J. Vitamin D and chronic pain. Pain 2009, 141:10-13.
136. Teegarden D., Donkin S.S. Vitamin D: Emerging new roles in insulin sensitivity. Nutr. Res. Rev. 2009, 22:82-92.
137. van Etten E., Stoffels K., Gysemans C., et al. Regulation of vitamin D homeostasis: Implications for the immune system. Nutr. Rev. 2008, 66:S125-S134.
138. Veith R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am. J. Clin. Nutr. 1999, 69:842-856.
139. Wagner C.L., Greer F.R. Prevention of rickets and vitamin D deficiency in infants, children, and adolescents. Am. Acad. Ped. 2008, 122:1142-1152.
140. Wang S. Epidemiology of vitamin D in health and disease. Nutr. Res. Rev. 2009, 22:188-203.
141. Wargovich M.J. Calcium, vitamin D and the prevention of gastrointestinal cancer. Nutrition and Cancer Prevention 1991, 291-304. Marcel Dekker, New York, NY. T.E. Moon, M.S. Micozzi (Eds.).
142. Wasserman R.H. Vitamin D and the dual processes of intestinal calcium absorption. J. Nutr. 2004, 134:3137-3139.
143. Wharton B., Bishop N. Rickets. Lancet 2003, 362:1389-1400.
144. Whitfield G.K., Hsieh J.C., Jurutka P.W., et al. Genomic actions of 1,25-dihydroxyvitamin D3. J. Nutr. 1995, 125:1690S-1694S.
145. Willett A.M. Vitamin E status and its relationship with parathyroid hormone and bone mineral status in older adults. Proc. Nutr. Soc. 2005, 64:193-203.
146. Ylikomi T., Iaaksi I., Lou Y.R., et al. Antiproliferative action of vitamin D. Vitam. Horm. 2002, 64:357-406.
147. Zemel M.B., Sun X. Calcitriol and energy metabolism. Nutr. Rev. 2008, 66:S139-S146.
148. Zhang R., Naughton D.P. Vitamin D in health and disease: Current perspectives. Nutr. J. 2010, 9:65-78.
149. Zittermann A. Vitamin D in preventive medicine: Are we ignoring the evidence?. Br. J. Nutr. 2003, 89:552-572.
150. Zittermann A., Schleithoff S.S., Koerfer R. Putting cardiovascular disease and vitamin D insufficiency into perspective. Br. J. Nutr. 2005, 94:483-492.
151. Atkinson J., Harroun T., Wassall S.R., et al. The location and behavior of α-tocopherol in membranes. Mol. Nutr. Food Res. 2010, 54:641-651.
152. Azzi A. The role of α-tocopherol in preventing disease. Eur. J. Nutr. 2004, 43:18-25.
153. Azzi A. Molecular mechanism of α-tocopherol action. Free Rad. Biol. Med. 2007, 46:16-21.
154. Azzi A., Gysin R., Kempná P., et al. The role of a-tocopherol in preventing disease: From epidemiology to molecular events. Mol. Aspects Med. 2003, 24:325-336.
155. Azzi A., Gysin R., Kempná P., et al. Regulation of gene expression by alpha-tocopherol. J. Biol. Chem. 2004, 385:585-591.
156. Banks R., Speakman J.R., Selman C. Vitamin E supplementation and mammalian lifespan. Mol. Nutr. Food Res. 2010, 54:719-725.
157. Birringer M. Analysis of vitamin E metabolites in biological specimen. Mol. Nutr. Food Res. 2010, 54:588-598.
158. Brigelius-Flohé R. Vitamin E: The shrew waiting to be tamed. Free Rad. Biol. Med. 2009, 46:543-554.
159. Constantinou C., Papas A., Constantinou A.I. Vitamin E and cancer: An insight into the anticancer activities of vitamin E isomers and analogs. Intl J. Cancer 2008, 123:739-752.
160. Cutler R.G. Oxidative stress profiling: Part I. Its potential importance in the optimization of human health. Ann. NY Acad. Sci. 2005, 1055:93-135.
161. Cutler R.G., Plummer J., Chowdhury K., Heward C. Oxidative stress profiling. Part II. Theory, technology and practice. Ann. NY Acad. Sci. 2005, 1055:136-158.
162. Di Donato I., Bianchi S., Federico A. Ataxia with vitamin E deficiency: Update of molecular diagnosis. Neurol. Sci. 2010, 31:511-515.
163. Eitenmiller R., Lee J. Vitamin E: Food Chemistry, Composition, and Analysis 2004, Marcel Dekker, New York, NY, 530 pp.
164. Frei B. Efficacy of dietary antioxidants to prevent oxidative damage and inhibit chronic disease. J. Nutr. 2004, 134:3196S-3198S.
165. Fukuzawa K. Dynamics of lipid peroxidation and antioxidation of α-tocopherol in membranes. J. Nutr. Sci. Vitaminol. 2008, 54:273-285.
166. Gille L., Staniek K., Rosenau T., Kozlov A.V. Tocopheryl quinones and mitochondria. Mol. Nutr. Food Res. 2010, 54:601-615.
167. Gohil K., Vasu V.T., Cross C.E. Dietary α-tocopherol and neuromuscular health: Search for optimal dose and molecular mechanisms continues!. Mol. Nutr. Food Res. 2010, 54:693-709.
168. Gray B., Swick J., Ronnenberg A.G. Vitamin E and adiponectin: Proposed mechanism for vitamin E-induced improvement in insulin sensitivity. Nutr. Rev. 2011, 69:155-161.
169. Huebbe P., Lodge J.K., Rimbach G. Implications of apolipoprotein E genotype on inflammation and vitamin E status. Mol. Nutr. Food Res. 2010, 54:623-630.
170. Ju J., Picinich S.C., Yang Z., et al. Cancer-preventive activities of tocopherols and tocotrienols. Carcinogenesis 2010, 31:533-542.
171. Vitamin E and Health 2004, New York Academy of Sciences, New York, NY, 463 pp. F. Kelly, M. Meydani, L. Packer (Eds.).
172. Kline K., Lawson K.A., Yu W., Sanders B.G. Vitamin E and cancer. Vitam. Horm. 2007, 76:435-461.
173. Lemaire-Ewing S., Desrumaux C., Néel D., Lagrost L. Vitamin E transport, membrane incorporation and cell metabolism: Is α-tocopherol in lipid rafts an oar in the lifeboat?. Mol. Nutr. Food Res. 2010, 54:631-640.
174. Manor D., Morley S. The α-tocopherol transfer protein. Vitam. Horm. 2007, 76:45-65.
175. Mardones P., Attilo R. Cellular mechanisms of vitamin E uptake: Relevance in a-tocopherol metabolism and potential implications for disease. J. Nutr. Biochem. 2004, 15:252-260.
176. Mène-Saffrané L., DellaPenna D. Biosynthesis, regulation and functions of tocochromanols in plants. Plant Physiol. Biochem. 2010, 48:301-309.
177. Min K.C. Structure and function of α-tocopherol transfer protein: Implications for vitamin E metabolism and AVED. Vitam. Horm. 2007, 76:23-44.
178. Muller D.P.R. Vitamin E and neurological function. Mol. Nutr. Food Res. 2010, 54:710-718.
179. Munteanu A., Zingg J.M. Cellular, molecular and clinical aspects of vitamin E and atherosclerosis prevention. Mol. Aspects Med. 2007, 28:538-590.
180. Ohnmacht S., Nava P., West R., et al. Inhibition of oxidative metabolism of tocopherols with ω-N-heterocyclic derivatives of vitamin E. Bioorg. Med. Chem. 2008, 16:7631-7638.
181. Pazdro R., Burgess J.R. The role of vitamin E and oxidative stress in diabetes complications. Mech. Ageing Dev. 2010, 131:276-286.
182. Powers S.K., Duarte J., Kavazis A.N., Talbert E.E. Reactive oxygen species are signalling molecules for skeletal muscle adaptation. Exp. Physiol. 2009, 95:1-9.
183. Quinn P.J. Molecular associations of vitamin E. Vitam. Horm. 2007, 76:67-98.
184. Reiter E., Jiang Q., Christen S. Anti-inflammatory properties of α- and γ-tocopherol. Mol. Aspects Med. 2007, 28:668-691.
185. Ricciarelli R., Argellati F., Pronzator M.A., Domenicotti C. Vitamin E and neurodegenerative diseases. Mol. Aspects Med. 2007, 28:591-606.
186. Rigotti A. Absorption, transport and tissue delivery of vitamin E. Mol. Aspects Med. 2007, 28:423-436.
187. Rimbach G., Minihane A.M., Majewicz J., et al. Regulation of cell signalling by vitamin E. Proc. Nutr. Soc. 2002, 61:415-425.
188. Ristow M., Zarse K. How increased oxidative stress promotes longevity and metabolic health: The concept of mitochondrial hormesis (mitohormesis). Exp. Gerontol. 2010, 45:410-418.
189. Schaffer S., Müller W.E., Eckert G.P. Tocotrienols: Constitutional effects in aging and disease. J. Nutr. 2005, 135:151-154.
190. Sen C.K., Khanna S., Roy S. Tocotrienols in health and disease: The other half of the natural vitamin E family. Mol. Aspects Med. 2007, 28:692-728.
191. Singh U., Devaraj S. Vitamin E: Inflammation and atherosclerosis. Vitam. Horm. 2007, 76:519-549.
192. Sohal R.S., Mockett R.J., Orr W.C. Mechanisms of aging: An appraisal of the oxidative stress hypothesis. Free Rad. Biol. Med. 2002, 5:575-586.
193. Sylvester P.W. Vitamin E and apoptosis. Vitam. Horm. 2007, 76:329-356.
194. Takada T., Suzuki H. Molecular mechanisms of membrane transport of vitamin E. Mol. Nutr. Food Res. 2010, 54:616-622.
195. Theile J.J., Ekanayake-Mudiyanselage S. Vitamin E in human skin: Organ-specific physiology and considerations for its use in dermatology. Mol. Aspects Med. 2007, 28:646-667.
196. Traber M.G. Vitamin E regulatory mechanisms. Ann. Rev. Nutr. 2007, 27:347-362.
197. Traber M.G. Vitamin E. Handbook of Vitamins 2007, 154-174. CRC Press, New York, NY. fourth ed. J. Zempleni, R.B. Rucker, D.B. McCormick, J.W. Suttie (Eds.).
198. Traber M.G. Regulation of xenobiotic metabolism, the only signaling function of α-tocopherol?. Mol. Nutr. Food Res. 2010, 54:661-668.
199. Traber M.G., Atkinson J. Vitamin E, antioxidant and nothing more. Free Rad. Biol. Med. 2007, 46:4-15.
200. Traber M.G., Hiroyuki A. Molecular mechanisms of vitamin E transport. Ann. Rev. Nutr. 1999, 19:343-355.
201. Villacorta L., Azzi A., Zingg J.M. Regulatory role of vitamins E and C on extracellular matrix components of the vascular system. Mol. Aspects Med. 2007, 28:507-537.
202. Wu J.H., Croft K.D. Vitamin E metabolism. Mol. Aspects Med. 2007, 28:437-452.
203. Zingg J.M. Modulation of signal transduction by vitamin E. Mol. Aspects Med. 2007, 28:481-506.
204. Zingg J.M., Azzi A., Meydani M. Genetic polymorphisms as determinants for disease-preventive effects of vitamin E. Nutr. Rev. 2008, 66:406-414.
205. Zingg J.M., Meydani M., Azzi A. α-Tocopheryl phosphate - an active lipid mediator?. Mol. Nutr. Food Res. 2010, 54:679-692.
206. Berkner K.L. The vitamin K-dependent carboxylase. Ann. Rev. Nutr. 2005, 25:127-149.
207. Berkner K.L. Vitamin K-dependent carboxylation. Vit. Hormones 2008, 78:131-156.
208. Booth S.L. Roles for vitamin K beyond coagulation. Ann. Rev. Nutr. 2009, 29:89-110.
209. Bügel S. Vitamin K and bone health in adult humans. Vit. Hormones 2008, 78:393-416.
210. Cashman K.D., O'Connor E. Does high vitamin K1 intake protect against bone loss in later life?. Nutr. Rev. 2008, 66:532-538.
211. Dahlbäck B., Villoutreix B.O. The anticoagulation protein C pathway. FEBS Letts 2005, 579:3310-3316.
212. Danziger J. Vitamin K-dependent proteins, warfarin, and vascular calcification. Clin. J. Am. Soc. Nephrol. 2008, 3:1504-1510.
213. Denisova N.A., Booth S.A. Vitamin K and sphingolipid metabolism: Evidence to date. Nutr. Rev. 2005, 63:111-121.
214. Ferland G. Vitamin K. Present Knowledge in Nutrition 2006, vol. I:220-232. ILSI Press, Washington, DC. ninth ed.
215. Greer F.R. Vitamin K the basics - what's new?. Early Human Dev. 2010, 86:S43-S47.
216. Iwamoto J., Takeda T., Sato Y. Menatetrenone (vitamin K2) and bone quality in the treatment of postmenopausal osteoporosis. Nutr. Rev. 2006, 64:509-517.
217. Kaneki M., Hosoi T., Ouchi Y., Orimo H. Pleiotropic actions of vitamin K: Protector of bone health and beyond?. Nutr. 2006, 22:845-852.
218. Lamson D.W., Plaza S.M. The anticancer effects of vitamin K. Alt. Med. Rev. 2003, 8:303-318.
219. Mizuta T., Ozaki I. Hepatocellular carcinoma and vitamin K. Vit. Hormones 2008, 78:435-442.
220. Napolitano.M., Mariani G., Lapecorella M. Hereditary combined deficiency of the vitamin K-dependent clotting factors. J. Rare Dis. 2010, 5:21-29.
221. Nelsestuen G.L., Shah A.M., Harvey S.B. Vitamin K-dependent proteins. Vit. Hormones 2000, 58:355-389.
222. Oldenburg J., Morinova M., Muller-Reible C., Watzka M. The Vitamin K cycle. Vit. Hormones 2008, 78:35-62.
223. Schurgers L.J., Cranenburg E.C.M., Vermeer C. Matrix Gla-protein: The calcification inhibitor in need of vitamin K. Thromb. Haemost. 2008, 100:593-603.
224. Shearer M.J. Vitamin K deficiency bleeding (VKDB) in early infancy. Blood Rev. 2008, 23:49-59.
225. Shearer M.J., Newman P. Metabolism and cell biology of vitamin K. Thromb. Haemost. 2008, 100:530-547.
226. Siguret V., Pautas E., Gouin-Thibault I. Warfarin therapy: Influence of pharmacogenetic and environmental factors on the anticoagulant response to warfarin. Vit. Hormones 2008, 78:247-264.
227. Stafford D.W. The vitamin K cycle. J. Thromb. Haemost. 2005, 3:1873-1878.
228. Suttie J.W. Vitamin K. Modern Nutrition in Health and Disease 2006, 412-425. Lippincott, New York, NY. tenth ed. M.E. Shils, M. Shike, A.C. Ross (Eds.).
229. Suttie J.W. Vitamin K. Handbook of Vitamins 2007, 111-152. CRC Press, New York, NY. fourth ed. J. Zemplini, R.B. Rucker, D.B. McCormick, J.W. Suttie (Eds.).
230. Suttie J.W. Vitamin K in Health and Disease 2009, CRC Press, New York, NY, pp. 224.
231. Uprichard J., Perry D.J. Factor X deficiency. Blood Rev. 2002, 16:97-110.
232. Vermeer C., Shearer M.J, Zitterman A., et al. Beyond deficiency: Potential benefits of increased intakes of vitamin K for bone and vascular health. Eur. J. Nutr. 2004, 43:325-335.
233. Aguirre.R., May J.N. Inflammation in the vascular bed: Importance of vitamin C. Pharmacol. Ther. 2008, 119:96-103.
234. Castro M.A., Beltrán F.A., Brauchi S., Concha I.I. A metabolic switch in brain: Glucose and lactate metabolism modulation by ascorbic acid. J. Neurochem. 2009, 110:423-440.
235. Corti A., Casini A.F., Pompella A. Cellular pathways for transport and efflux of ascorbate and dehydroascorbate. Arch. Biochem. Biophys. 2010, 500:107-115.
236. Douglas, R., Hemila, H., D'Souza, R., et al. 2004. Vitamin C for preventing and treating the common cold. Cochrane Database Syst. Rev. (CD000980).
237. Duarte T.L., Lunee J. Review: When is an antioxidant not an antioxidant? A review of novel actions of vitamin C. Free Radic. Res. 2005, 39:671-686.
238. Gebicki J.M., Nauser T., Domazou A., et al. Reduction of protein radicals by GSH and ascorbate: Potential biological significance. Amino Acids 2010, 39:1131-1137.
239. Harrison F.E., May J.M. Vitamin C function in the brain: Vital role of the ascorbate transporter SVCT2. Free Radic. Biol. Med. 2009, 46:719-730.
240. Hathcock J.N., Azzi A., Blumberg J., et al. Vitamins E and C are safe across a broad range of intakes. Am. J. Clin. Nutr. 2005, 81:736-745.
241. Johnston C.S., Steinberg F.M., Rucker R.B. Ascorbic acid. Handbook of Vitamins 2007, 489-520. CRC Press, New York, NY. fourth ed. J. Zempleni, R.B. Rucker, D.B. McCormick, J.W. Suttie (Eds.).
242. Kneckt P., Ritz J., Pereira M.A., et al. Antioxidant vitamins and coronary heart disease risk: A pooled analysis of 9 cohorts. Am. J. Clin. Nutr. 2004, 80:1508-1520.
243. Lane D.J.R., Lawen A. Ascorbate and plasma membrane electron transport - enzymes vs efflux. Free Radic. Biol. Med. 2009, 47:485-495.
244. Lee K.W., Lee H.J., Surh Y.J., Lee C.Y. Vitamin C and cancer chemoprevention: Reappraisal. Am. J. Clin. Nutr. 2003, 78:1074-1078.
245. Léger D. Scurvy: Re-emergence of nutritional deficiencies. Can. Fam. Physician 2008, 54:1403-1406.
246. Levine M. Vitamin C as an antioxidant: Evaluation of its role in disease prevention. J. Am. Coll. Nutr. 2003, 22:18-35.
247. Levine M., Katz A., Pakayatty S.J. Vitamin C. Modern Nutrition in Health and Disease 2006, 507-524. Lippincott, New York, NY. tenth ed. M.E. Shils, M. Shike, A.C. Ross (Eds.).
248. Linster C.L., van Schaftingen E. Vitamin C: Biosynthesis, recycling and degradation in mammals. FEBS J. 2007, 274:1-22.
249. Lykkesfeldt J., Poulsen H.E. Is vitamin C supplementation beneficial? Lessons learned from randomized controlled trials. Br. J. Nutr. 2010, 103:1251-1259.
250. Mandl J., Szarka A., Bánhegyi G. Vitamin C: Update on physiology and pharmacology. Br. J. Pharmacol. 2009, 157:1097-1110.
251. May J.M. How does ascorbic acid prevent endothelial dysfunction?. Free Radic. Biol. Med. 2000, 28:1421-1429.
252. Pauling L. Vitamin C and the Common Cold 1970, W.H. Freeman and Company, San Francisco, CA.
253. Rice M.E. Ascorbate regulation and its neuroprotective role in the brain. Trends Neurosci 2000, 23:209-216.
254. Rivas C.I., Zuniga F.A., Salas-Burgos A., et al. Vitamin C transporters. J. Physiol. Biochem. 2008, 64:357-375.
255. Savini I., Rossi A., Pierro C., et al. SVCT1 and SVCT2: Key proteins for vitamin C uptake. Amino Acids 2008, 34:347-355.
256. Smirnoff N. L-Ascorbic acid biosynthesis. Vit. Hormones 61 2001, 241-266.
257. Toohey J.I. Dehydroascrobid acid as an anti-cancer agent. Cancer Lett. 2008, 263:164-169.
258. Verrax J., Caderon P.B. The controversial place of vitamin C in cancer treatment. Biochem. Pharmacol. 2008, 76:1644-1652.
259. Wilson J.X. The physiological role of dehyrdoascorbic acid. FEBS Letts. 2002, 527:5-9.
260. Wilson J.X. Regulation of vitamin C transport. Ann. Rev. Nutr. 2005, 25:105-125.
261. Alexander-Kaufman K., Harper C. Transketolase: Observations in alcohol-related brain damage research. Intl. J. Biochem. Cell Biol. 2009, 41:717-720.
262. Balakumar P., Rohilla A., Krishan P., Solairaj P. The multifaceted therapeutic potential of benfotiamine. Pharmacol. Res. 2010, 61:482-488.
263. Bates C.J. Thiamine. Handbook of Vitamins 2007, 253-287. Marcel Dekker, New York, NY. fourth ed. J. Zemplini, R.B. Rucker, D.B. McCormick, J.W. Suttie (Eds.).
264. Beltramo E., Berrone E., Tarallo S., Porta M. Effects of thiamine and benoftiamine on intracellular glucose metabolism and relevance in the prevention of diabetic complications. Acta Diabetol. 2008, 45:131-141.
265. Bettendorff L., Wins P. Thiamin diphosphate in biological chemistry: New aspects of thiamin metabolism, especially triphosphate derivatives acting other than as cofactors. FEBS J. 2009, 276:2917-2925.
266. Butterworth R.F. Thiamin deficiency and brain disorders. Nutr. Res. Rev. 2003, 16:277-283.
267. Butterworth R.F. Thiamin. Modern Nutrition in Health and Disease 2006, 426-433. Lippincott, New York, NY. tenth ed. M.E. Shils, M. Shike, A.C. Ross, B. Caballero, R. Cousins (Eds.).
268. del Arco A., Satrústegui J. New mitochondrial carriers: An overview. Cell Molec. Life Sci. 2005, 62:2204-2227.
269. Frank R.A.W., Leeper F.J., Luisi B.F. Structure, mechanism and catalytic duality of thiamine-dependent enzymes. Cell Molec. Life Sci. 2007, 64:892-905.
270. Gibson G.E., Zhang H. Interactions of oxidative stress with thiamine homeostasis promote neurodegeneration. Neurochem. Intl. 2002, 40:493-504.
271. Gregory J.F. Bioavailability of thiamin. Eur. J. Clin. Nutr. 1997, 51:S34-S37.
272. Kluger R., Tittman K. Thiamin diphosphate catalysis: Enzymic and nonenzymic covalent intermediates. Chem. Rev. 2008, 108:1797-1833.
273. Lonsdale D. A review of the biochemistry, metabolism and clinical benefits of thiamin(e) and its derivatives. eCAM 2006, 3:49-59.
274. Malandrinos G., Louloudi M., Hadjiliadis N. Thiamine models and perspectives on the mechanism of action of thiamine-dependent enzymes. Chem. Soc. Rev. 2006, 35:684-692.
275. Martin P.R., Singleton C.K., Hiller-Sturmhöfel S. The role of thiamine deficiency in alcoholic brain disease. Alcohol Res. Health 2003, 27:134-142.
276. Pohl M., Sprenger G.A., Müller M. A new persepective on thiamine catalysis. Curr. Opin. Biotechnol. 2004, 15:335-342.
277. Rindi G., Laforenza U. Thiamine intestinal transport and related issues: Recent aspects. Proc. Soc. Exp. Biol. Med. 2000, 224:246-255.
278. Rios J.M. The THI-box riboswitch, or how RNA binds thiamin pyrophosphate. Cell Structure 2007, 15:259-265.
279. Schenk G., Duggleby R.G., Nixon P.F. Properties and functions of thiamin diphosphate dependent enzyme transketolase. Intl. J. Biochem. Cell Biol. 1998, 30:1297-1318.
280. Shannon B., Chipman D.M. Reaction mechanisms of thiamin diphosphate enzymes: New insights into the role of a conserved glutamate residue. FEBS J. 2009, 276:2447-2453.
281. Tittmann K. Reaction mechanisms of thiamin diphosphate enzymes: Redox reactions. FEBS J. 2009, 276:2454-2468.
282. Bates C.J. Bioavailability of riboflavin. Eur. J. Clin. Nutr. 1997, 51:S38-S42.
283. Bender D.A. Nutritional Biochemistry of the Vitamins 2009, Cambridge University Press, Cambridge, pp. 172-199. second ed.
284. Depeint F., Bruce W.R., Shangari N., et al. Mitochondrial function and toxicity: Role of B vitamin family on mitochondrial energy metabolism. Chem.-Biol. Interactions 2006, 163:94-112.
285. Foraker A.B., Khantwal C.M., Swaan P.W. Current perspectives on the cellular uptake and trafficking of riboflavin. Adv. Drug Deliv. Rev. 2003, 55:1467-1483.
286. Hefti M.H., Vervoot J., van Berkel W.J.H. Deflavination and reconstitution of flavoproteins. Tackling fold and function. Eur. J. Biochim. 2003, 270:4227-4242.
287. Leferink N.G.H., Heuts D.P.H.M., Fraaije M.W., van Berkel W.J.H. The growing VAO flavoprotein family. Arch. Biochem. Biophys. 2008, 474:292-301.
288. Mansour N.M., Sawhney M., Tamang D.G., et al. The bile/arenite/riboflavin transporter (BART) superfamily. FEBS J. 2007, 274:612-629.
289. McCormick D.B. Riboflavin. In: Modern Nutrition in Health and Disease 2006, 434-441. Lippincott, New York, NY. tenth ed. M.E. Shils, M. Shike, A.C. Ross, B. Caballero, R.J. Cousins (Eds.).
290. Powers H.J. Riboflavin (vitamin B-2) and health. Am. J. Clin. Nutr. 2003, 77:1352-1360.
291. Rivlin R.S. Riboflavin. Handbook of Vitamins 2007, 233-251. CRC Press, New York, NY. fourth ed. J. Zemplini, R.B. Rucker, B.B. McCormick, J.W. Suttie (Eds.).
292. Said H.M. Recent advances in carrier-mediated intestinal absorption of water-soluble vitamins. Ann. Rev. Physiol. 2004, 66:419-446.
293. Stuehr D.J., Tejero J., Haque M.M. Structural and mechanistic aspects of flavoproteins: Electron transfer through the nitric oxide synthase flavoprotein domain. FEBS J. 2009, 276:3959-3974.
294. Al-Mohaissen M.A., Pun S.C., Frohlish J.J. Niacin: From mechanisms of action to therapeutic uses. Mini Rev. Med. Chem. 2010, 10:204-217.
295. Alsheikh-Ali A.A., Karas R.H. The safety of niacin in the US Food and Drug Administration adverse effect reporting database. Am. J. Cardiol. 2008, 101(Suppl.):9B-13B.
296. Bodor E.T., Offermans S. Nicotinic acid: An old drug with a promising future. Br. J. Pharmacol. 2008, 153:S68-S75.
297. + precursor vitamins in human nutrition. Ann. Rev. Nutr. 2008, 28:115-130.
298. Bourgeois C., Cervantes-Laurean D., Moss J. Niacin. Present Knowledge in Nutrition 2006, 442-451. Lippincott, New York, NY. tenth ed. M.E. Shils, M. Shike, A.C. Ross (Eds.).
299. Brooks E.L., Kuvin J.T., Karas R.H. Niacin's role in the statin era. Expert Opin. Pharmacother. 2010, 11:2291-2300.
300. Bruckert E., Labreuche J., Amarenco P. Meta-analysis of the effect of nicotinic acid alone or in combination on cardiovascular events and atherosclerosis. Atherosclerosis 2010, 210:353-361.
301. Capuzzi D.M., Morgan J.M., Brusco O.A., Intenzo C.M. Niacin dosing: Relationship to benefits and adverse effects. Curr. Atheroscler. Rep. 2000, 2:64-71.
302. Depeint F., Bruce W.R., Shangari N., et al. Mitochondrial function and toxicity: Role of B vitamin family on mitochondrial energy metabolism. Chem. Biol. Interact. 2006, 163:94-112.
303. DiPalma J.R., Thayer W.S. Use of niacin as a drug. Annu. Rev. Nutr. 1991, 11:169-187.
304. Farmer J.S. Nicotinic acid: A new look at an old drug. Curr. Atheroscler. Rep. 2009, 11:87-92.
305. Gille A., Bodor E.T., Ahmed K., Offermans S. Nicotinic acid: Pharmacological effects and mechanisms of action. Annu. Rev. Pharmacol. Toxicol. 2008, 48:79-106.
306. Guyton J.R., Bays H.E. Safety considerations with niacin therapy. Am. J. Cardiol. 2007, 99(Suppl.):22C-31C.
307. Harmeyer J., Kollenkirchen U. Thiamin and niacin in ruminant nutrition. Nutr. Res. Rev. 1989, 2:201-225.
308. Hegyi J., Schwarts R.A., Hegyi V. Pellagra: Dermatitis, dementia and diarrhea. Intl. J. Dermatol. 2004, 43:1-5.
309. Ido Y. Pyridine nucleotide redox abnormalities in diabetes. Antioxid. Redox Signal. 2007, 9:931-942.
310. Jacob R.A. Niacin. Present Knowledge in Nutrition 2006, 260-268. ILSI Press, Washington, DC. ninth ed. B.A. Bowman, R.M. Russell (Eds.).
311. Kamanna V.S., Kashyap M.L. Mechanism of action of niacin. Am. J. Cardiol. 2008, 101(Suppl.):20B-26B.
312. Kamanna V.S., Ganji S.H., Kashyap M.L. The mechanism and mitigation of niacin-induced flushing. Intl. J. Clin. Pract. 2009, 63:1369-1377.
313. Kirkland J.B. Niacin. Handbook of Vitamins 2007, 191-232. CRC Press, New York, NY. fourth ed. J. Zemplini, R.B. Rucker, D.B. McCormick, J.W. Suttie (Eds.).
314. Maiese K., Chong Z.Z., Hou J., Shang Y.C. The vitamin nicotinamide: Translating nutrition into clinical care. Molecules 2009, 14:3446-3485.
315. Messamore E., Hoffman W.F., Yao J.K. Niacin sensitivity and the arachidonic acid pathway in schizophrenia. Schizophrenia Res. 2010, 122:248-256.
316. Niehoff I.D., Hüther L., Lebzien P. Niacin for dairy cattle: A review. Br. J. Nutr. 2009, 101:5-19.
317. Sood A., Arora R. Mechanisms of flushing due to niacin, and abolition of these effects. J. Clin. Hyperten. 2009, 11:685-689.
318. 3: From metabolism to therapies. J. Pharmacol. Exp. Therapeut. 2008, 324:883-893.
319. Vosper H. Niacin: A re-emerging pharmaceutical for the treatment of dyslipidemia. Br. J. Pharmacol. 2009, 158:429-441.
320. Allen G.F.G., Land J.M., Heales S.J.R. A new perspective on the treatment of aromatic l-amino acid decarboxylase deficiency. Molec. Genet. Metab. 2009, 97:6-14.
321. Aufiero E., Stitk T.P., Foye P.M., Chen B. Pn hydrochloride treatment of carpal tunnel syndrome: A review. Nutr. Rev. 2004, 62:96-104.
322. Baxter P. Pn-dependent seizures: A clinical and biochemical conundrum. Biochim. Biophys. Acta 2003, 1647:36-41.
323. 6. Br. J. Nutr. 1999, 81:7-20.
324. 6. Handbook of Vitamins 2007, 315-359. CRC Press, New York, NY. fourth ed. J. Zempleni, R.B. Rucker, D.B. McCormick, J.W. Suttie (Eds.).
325. Depeint F., Bruce W.R., Shangari N., et al. Mitochondrial function and toxicity: Role of B vitamins in the one-carbon transfer pathways. Chem. Biol. Interact. 2006, 163:113-132.
326. Gregory J.F. Bioavailability of vitamin B-6. Eur. J. Clin. Nutr. 1997, 51:S43-S48.
327. Gregory J.F. Nutritional properties and significance of vitamin glycosides. Ann. Rev. Nutr. 1998, 18:277-296.
328. Lheureux P., Penaloza A., Gris M. Pn in clinical toxicology: A review. Eur. J. Emerg. Med. 2005, 12:78-85.
329. 6. Modern Nutrition in Health and Disease 2006, 452-461. Lippincott, New York, NY. tenth ed. M.E. Shils, M. Shike, A.C. Ross (Eds.).
330. McCormick D.B. Vitamin B-6. Present Knowledge in Nutrition 2006, 269-277. ILSI, Washington, DC. ninth ed. B.A. Bowman, R.M. Russell (Eds.).
331. 6. Nutr. Res. Rev. 2001, 14:257-265.
332. Sánchez-Moreno C., Jiménez-Excrig A., Martín A. Stroke: Roles of B vitamins, homocysteine and antioxidants. Nutr. Res. Rev. 2009, 22:49-67.
333. Schneider G., Kack H., Lindquist Y. The manifold of vitamin B6 dependent enzymes. Structure 2000, 8:R1-R6.
334. 6 and immune competence. Nutr. Rev. 1993, 51:217-225.
335. Beckett D. Biotin sensing: Universal influence of biotin status on transcription. Ann. Rev. Genet. 2007, 41:443-464.
336. Beckett D. Biotin sensing at the molecular level. J. Nutr. 2009, 139:167-170.
337. Brownsey R.W., Boone A.W., Elliot J.E., et al. Regulation of acetyl-CoA carboxylase. Biochem. Soc. Trans. 2006, 34:223-227.
338. Chapman-Smith A., Cronan J.E. Molecular biology of biotin attachment to proteins. J. Nutr. 1999, 129:477S-484S.
339. Cronan J.E., Waldrop G.L. Multi-subunit acetyl-CoA carboxylases. Progr. Lipid Res. 2002, 41:407-435.
340. Dakshinamurti K. Biotin - a regulator of gene expression. J. Nutr. Biochem. 2005, 16:419-423.
341. Fernandez-Mejia C. Pharmacological effects of biotin. J. Nutr. Biochem. 2005, 16:424-427.
342. Hassam.Y.I., Zemplini Y. A novel, enigmatic histone modification: Biotinylation of histones by holocarboxylase synthetase. Nutr. Rev. 2008, 66:721-725.
343. McMahan R.J. Biotin in metabolism and molecular biology. Ann. Rev. Nutr. 2002, 22:221-239.
344. Mock D.M. Biotin. Handbook of Vitamins 2007, 361-383. CRC Press, New York, NY. fourth ed. J. Zemplini, R.B. Rucker, D.B. McCormick, J.W. Suttie (Eds.).
345. Mock D.M. Marginal biotin deficiency is common in normal human pregnancy and is highly teratogenic in mice. J. Nutr. 2009, 139:154-157.
346. Rodrigues-Melendez M., Zemplini J. Regulation of gene expression by biotin. J. Nutr. Biochem. 2003, 14:680-690.
347. Said H.M. Cell and molecular aspects of human intestinal biotin absorption. J. Nutr. 2009, 139:158-162.
348. van den Berg H. Bioavailability of biotin. Eur. J. Clin. Nutr. 1997, 51:S60-S61.
349. Wolf B. Biotinidase: Its role in biotinidase deficiency and biotin metabolism. J. Nutr. Biochem. 2005, 16:441-445.
350. Wolf B. Clinical issues and frequent questions about biotinidase deficiency. Mol. Gen. Metab. 2010, 100:6-13.
351. Zempleni J. Uptake, localization and noncarboxylase roles of biotin. Ann. Rev. Nutr. 2005, 25:175-196.
352. Zempleni J. Biotin. Biofactors 2009, 35:36-46.
353. Zempleni J., Chew Y.C., Hassan Y.I., Wijeratne S.K. Epigenetic regulation of chromatin structure and gene function by biotin: Are biotin requirements being met?. Nutr. Rev. 2008, 66:S46-S48.
354. Zempleni J., Hassan.Y.I., Wijeratne S.S.K. Biotin and biotinidase deficiency. Expert Rev. Endocrinol. Metab. 2008, 3:715-724.
355. Folmes C.D.L., Lopaschuk G.D. Role of malonyl-CoA in heart disease and the hypothalamic control of obesity. Cardiovas. Res. 2007, 73:278-287.
356. Leonoardi R., Zhang Y.M., Rock C.O., Jackowski S. Coenzyme A: Back in action. Progr. Lipid Res. 2005, 44:125-153.
357. Li L.O., Klett E.L., Coleman R.A. Acyl-CoA synthesis, lipid metabolism and lipotoxicity. Biochim. Biophys. Acta 2010, 1801:246-251.
358. Miller J.W., Rogers L.M., Rucker R.B. Pantothenic acid. Present Knowledge in Nutrition 2006, 327-339. ILSI Press, Washington, DC. ninth ed. B.A. Bowman, R.M. Russell (Eds.).
359. Rucker R.B., Bauerly K. Pantothenic acid. Handbook of Vitamins 2007, 289-313. CRC Press, New York, NY. fourth ed. J. Zempleni, R.B. Rucker, D.B. McCormick, J.W. Suttie (Eds.).
360. Shindow H., Hishikawa D., Harayama T., Yuki K., Shoizu T. Recent progress on acyl CoA:lysophospholipid aceltransferase research. J. Lipid Res. 2009, 50:S46-S51.
361. Spry C., Kirk K., Saliba K.J. Coenzyme A biosynthesis: An antimicrobial drug target. FEMS Microbiol. Rev. 2008, 32:56-106.
362. van den Berg H. Bioavailability of pantothenic acid. Eur. J. Clin. Nutr. 1997, 51:S62-S63.
363. Watkins P.A. Very-long-chain acyl-CoA synthetases. J. Biol. Chem. 2008, 283:1773-1777.
364. Wolfgang M.J., Lane M.D. The role of hypothalamic malonyl-CoA in energy homeostasis. J. Biol. Chem. 2006, 281:37265-37269.
365. Bailey L.B. Folic acid. Handbook of Vitamins 2007, 385-412. CRC Press, New York, NY. fourth ed. J. Zempleni, R.B. Rucker, D.B. McCormick, J.W. Suttie (Eds.).
366. Bailey L.B., Gregory J.F. Folate. Present Knowledge in Nutrition 2006, 278-301. ILSI Press, Washington, DC. ninth ed. B.A. Bowman, R.M. Russell (Eds.).
367. Blom H.J., Smulders Y. Overview of homocysteine and folate metabolism, with special references to cardiovascular disease and neural tube defects. J. Inherit. Metab. Dis. 2011, 34:75-81.
368. Brustolin S., Giugliani R., Félix T.M. Genetics of homocysteine metabolism and associated disorders. Br. J. Med. Biol. Res. 2010, 43:1-7.
369. Carmel R. Folic acid. Modern Nutrition in Health and Disease 2006, 470-481. Lippincott, New York, NY. tenth ed. M.E. Shils, M. Shike, A.C. Ross (Eds.).
370. Caudill M.A. Folate bioavailability: Implications for establishing dietary recommendations and optimizing status. Am. J. Clin. Nutr. 2010, 91(Suppl.):1455S-1460S.
371. Cuskelly G.J., Mooney K.M., Young I.S. Folate and vitamin B12: Friendly or enemy nutrients for the elderly. Proc. Nutr. Soc. 2007, 66:548-558.
372. Day O. Nutritional interpretation of folic acid interventions. Nutr. Rev. 2009, 67:235-244.
373. Devos L., Chanson A., Liu Z., et al. Associations between single nucleotide polymorphisms in folate uptake and metabolizing genes with blood folate, homocysteine, and DNA uracil concentrations. Am. J. Clin. Nutr. 2008, 88:1149-1158.
374. Di Minno M.N.D., Tremoli E., Coppola A., et al. Homocysteine and arterial thrombosis: Challenge and opportunity. Thromb. Haemost. 2010, 103:942-961.
375. Duthie S.J. Folate and cancer: How DNA damage, repair and methylation impact colon carcinogenesis. J. Inherit. Metab. Dis. 2011, 34:101-109.
376. Eicholzer M., Tönz O., Zimmermann R. Folic acid: A public health challenge. Lancet 2006, 367:1352-1361.
377. Fingas P.M., Wright A.J.A., Wolfe C.A., et al. Is there more to folates than neural-tube defects?. Proc. Nutr. Soc. 2003, 62:591-598.
378. Folstein M., Liu T., Peter I., et al. The homocysteine hypothesis of depression. Am. J. Psychiatry 2007, 164:861-867.
379. Giovannucci E. Epidemiological studies of folate and colorectal neoplasia: A review. J. Nutr. 2002, 132:2350S-2355S.
380. Gregory J.F., Quinlivan E.P. In vivo kinetics of folate metabolism. Ann. Rev. Nutr. 2002, 22:199-220.
381. Hamid A., Wani N.A., Kaur J. New perspectives on folate transport in relation to alcoholism-induced folate malabsorption - association with epigenome stability and cancer development. FEBS J. 2009, 276:2175-2191.
382. Heseker H.B., Mason J.B., Selub J., et al. Not all cases of neural-tube defect can be prevented by increasing the intake of folic acid. Br. J. Nutr. 2009, 102:173-180.
383. Kaman B.A., Smith A.K. A review of folate receptor alpha cycling and 5-methyltetrahydrofolate accumulation with an emphasis on cell models in vitro. Adv. Drug Deliv. Rev. 2004, 56:1085-1097.
384. Kim Y.I. Role of folate in colon cancer development and progression. J. Clin. Nutr. 2003, 133:3731S-3739S.
385. Kono S., Chen K. Genetic polymorphisms of methylenetetrahydrofolate reductase and colorectal cancer and adenoma. Cancer Sci. 2005, 96:535-542.
386. Koury M.J., Ponka P. New insights into erythropoiesis: The roles of folate, vitamin B12, and iron. Ann. Rev. Nutr. 2004, 24:105-131.
387. Lawrence M.A., Chai W., Kara R., et al. Examination of selected national policies towards mandatory folic acid fortification. Nutr. Rev. 2009, 67:S73-S78.
388. Manolescu B.N., Oprea E., Farcasanu I.C., et al. Homocysteine and vitamin therapy in stroke prevention and treatment: A review. Acta Biochim. Pol. 2010, 57:467-477.
389. McCully K.S. Homocysteine, vitamins, and vascular disease prevention. Am. J. Clin. Nutr. 2007, 86(Suppl.):1563S.
390. McNulty H., Pentieva K. Folate bioavailability. Proc. Nutr. Soc. 2004, 63:526-529.
391. Moat S.J., Lang D., McDowell I.F.W., et al. Folate, homocysteine, endothelial function and cardiovascular disease. J. Nutr. Biochem. 2004, 15:64-79.
392. Picciano M.F., Yetley E.A., Coates P.M., McGuire M.K. Update on folate and human health. Nutr. Today 2009, 44:142-152.
393. Pitkin R.M. Folate and neural tube defects. Am. J. Clin. Nutr. 2007, 85(Suppl.):285S-288S.
394. Quinlivan E.P., Hanson A.D., Gregory J.F. The analysis of folate and its metabolic precursors in biological samples. Anal. Biochem. 2006, 348:163-184.
395. Rush D. Periconceptional folate and neural tube defect. Am. J. Clin. Nutr. 1994, 59:511S-516S.
396. Smith A.D., Kim Y.I., Refsum H. Is folic acid good for everyone?. Am. J. Clin. Nutr. 2008, 87:517-533.
397. Smulders Y.M., Blom H.J. The homocysteine controversy. J. Inherit. Metab. Dis. 2011, 34:93-99.
398. Spence J.D. Homocysteine-lowering therapy: A role in stroke prevention?. Lancet Neurol. 2007, 6:830-838.
399. Stover P.J. One-carbon metabolism-genome interactions in folate-associated pathologies. J. Nutr. 2009, 139:2402-2405.
400. Tamura T., Picciano M.F. Folate and human reproduction. Am. J. Clin. Nutr. 2006, 83:993-1016.
401. Tibbetts A., Appling D.R. Compartmentalization of mammalian folate-mediated one-carbon metabolism. Ann. Rev. Nutr. 2010, 30:57-81.
402. Ulrich C.M. Folate and caner prevention - where to next: Counterpoint. Cancer Epidemiol. Biomarkers Prev. 2008, 17:226-230.
403. Wilson C.P., McNulty H., Scott J.M., et al. The MTHFR C677T polymorphism, B-vitamins and blood pressure. Proc. Nutr. Soc. 2010, 69:156-165.
404. Xia W., Low P.S. Folate-targeted therapies for cancer. J. Med. Chem. 2010, 53:6811-6824.
405. Bailey L.B. Folate and vitamin B12 recommended intakes and status in the United States. Nutr. Rev. 2004, 62:S14-S20.
406. Birn H. The kidney in vitamin B12 and folate homeostasis: Characterization of receptors for tubular uptake of vitamins and carrier proteins. Am. J. Physiol. Renal Physiol. 2006, 291:F22-F36.
407. Bridden A. Homocysteine in the context of cobalamin metabolism and deficiency states. Amino Acids 2003, 24:1-12.
408. 12. Chem Rev. 2005, 105:2075-2149.
409. 12). Modern Nutrition in Health and Disease 2006, 482-497. Lippincott, New York, NY. tenth ed. M.E. Shils, M. Shike, A.C. Ross (Eds.).
410. Elmadfa I., Singer I. Vitamin B-12 and homocysteine status among vegetarians: A global perspective. Am. J. Clin. Nutr. 2009, 89(Suppl.):1693S-1698S.
411. 12) levels in blood. Clin. Biochem. 2003, 36:585-590.
412. 12 metabolism: Eight complementation groups - eight genes. Exp. Rev. Molec. Med. 2010, 12:1-20.
413. 12. Handbook of Vitamins 2007, 413-457. CRC Press, New York, NY. fourth ed. J. Zempleni, R.B. Rucker, D.B. McCormick, J.W. Suttie (Eds.).
414. Herrmann W., Geisel J. Vegetarian lifestyle and monitoring of vitamin B-12 status. Clin. Chim. Acta 2002, 326:47-59.
415. 12 and iron. Ann. Rev. Nutr. 2004, 24:105-131.
416. 12: Chemistry and biochemistry. Biochem. Soc. Trans. 2005, 33:806-810.
417. Li F., Watkins D., Rosenblatt D.S. Vitamin B12 and birth defects. Molec. Cell Gen. Metab. 2009, 98:166-172.
418. Monsen A.L.B., Ueland P.M. Homocysteine and methylmalonic acid in diagnosis and risk assessment from infancy to adolescence. Am. J. Clin. Nutr. 2003, 78:7-21.
419. 12 and folate depletion in cognition: A review. Neurol. India 2004, 52:310-318.
420. Scalabrino G. The multi-faceted basis of vitamin B12 (cobalamin) neurotrophism in adult central nervous system: Lessons learned from its deficiency. Progr. Neurol. 2009, 88:203-220.
421. 12. Eur. J. Clin. Nutr. 1997, 51:S49-S53.
422. Smith A.D., Refsum H. Vitamin B-12 and cognition in the elderly. Am. J. Clin. Nutr. 2009, 89(Suppl.):707S-711S.
423. 12. Present Knowledge in Nutrition 2006, 302-313. ILSI Press, Washington, DC. eighth ed. B.A. Bowman, R.M. Russell (Eds.).
424. Stabler S.P., Allen R.H. Vitamin B12 deficiency as a worldwide problem. Ann. Rev. Nutr. 2004, 24:299-326.
425. 12 in health and disease. Nutr. Rev. 2004, 62:S3-S12.
426. Toh B.H., van Driel I.R., Gleeson P.A. Pernicious anemia. N. Engl. J. Med. 2006, 337:1441-1448.
427. Watanabe F. Vitamin B12 sources and bioavailability. Exp. Biol. Med. 2007, 232:1266-1274.
428. Zetterberg H. Methylenetetrahydrofolate reductase and transcobalamin genetic polymorphisms in human spontaneous abortion: Biological and clinical implications. Reprod. Biol. Endocrinol. 2004, 2:7-15.
429. Arduini A., Bonomini M., Savica V., et al. Carnitine in metabolic disease: Potential for pharmacological intervention. Pharmacol. Therapeut. 2008, 120:149-156.
430. Calabrese V., Stella A.M.G., Calvani M., Allan D. Acetylcholine and cellular response: Roles in nutritional redox homeostasis and regulation of longevity genes. J. Nutr. Biochem. 2005, 17:73-88.
431. Ferrari R., Merli E., Cicchitelli G., et al. Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: A review. Ann. NY Acad. Sci. 2004, 1033:79-91.
432. Hathcock J.N., Shao A. Risk assessment for carnitine. Reg. Toxicol. Pharmacol. 2006, 46:23-28.
433. Jones L.L., McDonald D.A., Borum P.R. Acylcarnitines: Role in brain. Prog. Lipid Res. 2010, 49:61-75.
434. Mingorance C., Rodriguez-Rodriguez R., Justo M.L., et al. Pharmacological effects and clinical applications of propionyl-L-carnitine. Nutr. Rev. 2011, 69:279-290.
435. Mingrove G. Carnitine in type 2 diabetes. Ann. NY Acad. Sci. 2004, 1033:99-107.
436. Natecz K.A., Miecz D., Berezowski V., Cecchelli R. Carnitine: Transport and physiological functions in the brain. Mol. Aspects Med. 2004, 25:551-567.
437. Rebouche G.J. Carnitine. Present Knowledge in Nutrition 2006, 340-351. ILSI Press, Washington, DC. ninth ed. B.A. Bowman, R.M. Russell (Eds.).
438. Stanley C.A. Carnitine deficiency disorders in children. Ann. NY Acad. Sci. 2004, 1033:42-51.
439. Strijbis K., Vaz F.M., Distel B. Enzymology of the carnitine biosynthesis pathway. IUBMB Life 2010, 62:357-362.
440. Wolf G. The discovery of a vitamin role for carnitine: The first 50 years. J. Nutr. 2006, 136:2131-2134.
441. Zammit V.A., Ramsay R.R., Bonomini M., Arduini A. Carnitine, mitochondrial function and therapy. Adv. Drug Deliv. Rev. 2009, 61:1353-1362.
442. Garrow T.A. Choline. Handbook of Vitamins 2007, 459-487. CRC Press, Washington, DC. fourth ed. J. Zempleni, R.B. Rucker, D.B. McCormick, J.W. Suttie (Eds.).
443. Glunde K., Ackerstaff E., Mori N., et al. Choline phospholipid metabolism in cancer: Consequences for molecular pharmaceutical interventions. Molec. Pharmaceut. 2006, 3:496-506.
444. Newborne P.M. Choline deficiency associated with diethaniolamine carcinogenicity. Toxicol. Sci. 2002, 67:1-3.
445. Ueland P.M. Choline and betaine in health and disease. J. Inherit. Metab. Dis. 2011, 34:3-15.
446. Zeisel S.H. Nutritional genomics: Defining the dietary requirement and effects of choline. J. Nutr. 2011, 141:531-534.
447. Zeisel S.H., da Costa K.A. Choline: An essential nutrient for public health. Nutr. Rev. 2009, 67:615-623.
448. Butt M.S., Sultan M.T. Green tea: Nature's defense against malignancies. Crit. Rev. Food Sci. Nutr. 2009, 49:463-473.
449. Cederroth C.R., Nef S. Soy, phyoestrogens and metabolism: A review. Molec. Cell. Endocrinol. 2009, 304:30-42.
450. Crozier A., del Rio D., Clifford M.N. Bioavailability of dietary flavonoids and phenolic compounds. Molec. Aspects Med. 2010, 31:446-467.
451. de Souza P.L., Russel P.J., Kearsley J.H., Howes L.G. Clinical pharmacology of isoflavone and its relevance for potential prevention of prostate cancer. Nutr. Rev. 2010, 68:542-555.
452. del Rio D., Borges G., Crozier A. Berry flavonoids and phenolics: Bioavailability and evidence of protective effects. Br. J. Nutr. 2010, 104:S67-S90.
453. Galleano M., Oteiza P.I., Fraga C.G. Cocoa, chocolate and cardiovascular disease. J. Cardiovasc. Pharmacol. 2009, 54:484-490.
454. García-Lafuente A., Guillamón E., Villares A., et al. Flavonoids as anti-inflammatory agents: Implications in cancer and cardiovascular disease. Inflamm. Res. 2009, 58:537-552.
455. González-Gellego J., García-Mediavilla M.V., Sánchez-Campos S., Tunón M.J. Fruit polyphenols, immunity and inflammation. Br. J. Nutr. 2010, 104:S15-S27.
456. Hodgson J.M., Croft K.D. Tea flavonoids and cardiovascular health. Molec. Aspects Med. 2010, 31:495-502.
457. Huntley A.L. The health benefits of berry flavonoids for menopausal women: Cardiovascular disease, cancer and cognition. Maturitas 2009, 63:297-301.
458. Ørgaard A., Jensen L. The effects of soy isoflavones on obesity. Exp. Biol. Med. 2008, 233:1066-1080.
459. Poulsen R.C., Kruger M.C. Soy phytoestrogens: Impact on postmenopausal bone loss and mechanisms of action. Nutr. Rev. 2008, 66:359-374.
460. Prasain J.K., Carlson S.H., Wyss J.M. Flavonoids and age related disease: Risk, benefits and critical windows. Maturitas 2010, 66:163-171.
461. Rastmanesh R. High polyphenol, low probiotic diet for weight loss because of intestinal microbiota interaction. Chem. Biol. Interact. 2010, 189:1-8.
462. Flavonoids in Health and Disease 2003, Marcel Dekker, New York, NY, 467 pp. C.A. Rice-Evans, L. Packer (Eds.).
463. Romier B., Schneider Y.J., Larondell Y., During A. Dietary polyphenols can modulate the intestinal inflammatory response. Nutr. Rev. 2009, 67:363-378.
464. Ross J.A., Kasum C.M. Dietary flavonoids: Bioavailability, metabolic effects, and safety. Annu. Rev. Nutr. 2002, 22:19-34.
465. Spencer J.P.E. The impact of fruit flavonoids on memory and cognition. Br. J. Nutr. 2010, 104(S40-S47).
466. Trzeciakiewicz A., Habauzit V., Horcajada M.N. When nutrition interacts with osteoblast function: Molecular mechanisms of polyphenols. Nutr. Res. Rev. 2009, 22:68.
467. Vargas A.J., Burd R. Hormesis and synergy: Pathways and mechanisms of quercetin in cancer prevention and management. Nutr. Rev. 2010, 68:418-428.
468. Bennett M., Onnebo S.M.N., Azevedo C., Saiardi A. Inosital pyrophosphates: Metabolism and signaling. Cell Mol. Life Sci. 2006, 63:552-564.
469. Berridge M.J. Inositol triphosphate and calcium signaling mechanisms. Biochim. Biophys. Acta 2009, 1793:933-940.
470. Mitchell R.H. Inositol derivatives: Evolution and functions. Nature Rev. Molec. Cell Biol. 2008, 9:151-161.
471. Shears S.B. Molecular basis for the integration of inositol phosphate signaling pathways via human ITPK1. Adv. Enzyme Reg. 2009, 49:87-96.
472. York J.D. Regulation of nuclear processes by inositol polyphosphates. Biochim. Biophys. Acta 2006, 1761:552-559.
473. Bilska A., Wlodek L. Lipoic acid - the drug of the future. Pharmacol. Rep. 2005, 57:570-577.
474. Maczurek A., Hager K., Kenklies M., et al. Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer's disease. Adv. Drug Deliv. Rev. 2008, 60:1463-1470.
475. Shay K.P., Moreau R.F., Smith E.J., et al. Alpha-lipoic acid as a dietary supplement: Molecular mechanisms and therapeutic potential. Biochem. Biophys. Acta 2009, 1790:1149-1160.
476. Singh U., Jialal I. Alpha-lipoic acid supplementation and diabetes. Nutr. Rev. 2008, 66:646-657.
477. Carpentier S., Knaus M., Suh M. Associations between lutein, zeaxanthin, and age-related macular degeneration: An overview. Crit. Rev. Food Sci. Nutr. 2009, 49:313-326.
478. Giovannucci E. A review of epidemiologic studies of tomatoes, lycopene and prostate cancer. Proc. Soc. Exp. Biol. Med. 2002, 227:852-859.
479. Hammond B.R. Possible role of dietary lutein and zeaxanthin in visual development. Nutr. Rev. 2008, 66:695-702.
480. Krishnadev N., Meleth A.D., Chew.E.Y. Nutritonal supplements for age-related macular degeneration. Curr. Opin. Ophthalmol. 2010, 21:184-189.
481. Lindshield B.L., Canene-Adams K., Erdman J.W. Lycopenoids: Are the lycopene metabolites bioactive?. Arch. Biochem. Biophys 2007, 458:136-140.
482. Loane E., Nolan J.M., O'Donovan O., et al. Transport and retinal capture of lutein and zeaxanthin with reference to age-related macular degeneration. Surv. Ophthalmol. 2008, 53:68-81.
483. Maiani G., Castón M.J.P., Catasta G., et al. Carotenoids: Actual knowledge on food sources, intakes, stability and bioavailability and their protective role in humans. Mol. Nutr. Food Res. 2009, 53:S194-S218.
484. Mein J.R., Lian F., Wang X.D. Biological activity of lycopene metabolites: Implications for cancer prevention. Nutr. Rev. 2008, 66:667-683.
485. van Breeman R.B., Pajkovic N. Multitargeted therapy of cancer by lycopene. Cancer Lett. 2008, 269:339-351.
486. Wong I.Y., Koo S.C.Y., Chan C.W.N. Prevention of age-related macular degeneration. Int. Ophthalmol. 2011, 31:73-82.
487. Brosnan M.E., Brosnan J.T. Orotic acid excretion and arginine metabolism. J. Nutr. 2007, 137:1656S-1661S.
488. Salerno C., Crifo C. Diagnostic value of urinary orotic acid levels: Applicable separation methods. J. Chromatog. 2002, 781:57-71.
489. Wang Y.M., Hu X.Q., Xue Y., et al. Study of the possible mechanism of orotic acid-induced fatty liver in rats. Nutrition 2011, 27:571-575.
490. Killgore J., Smidt C., Duich L., et al. Potential physiological importance of pyrroloquinoline quinone. Alt. Med. Rev. 2009, 14:268-277.
491. Stites T.E., Mitchell A.E., Rucker R.B. Physiological importance of quinoenzymes and the o-quinone family of cofactors. J. Nutr. 2000, 130:719-727.
492. Bentinger M., Brismar K., Dallner G. The antioxidant role of coenzyme Q. Mitochondrion 2007, 7S:S41-S50.
493. Bentinger M., Tekle M., Dallner G. Coenzyme Q - biosynthesis and functions. Biochem. Biophys. Res. Commun. 2007, 396:74-79.
494. 10) and an overview of function. Mitochondrion 2007, 7S:S2-S7.
495. Gille L., Rosenau T., Kozlov A.V., Gregor W. Ubiquinone and tocopherol: Dissimilar siblings. Biochem. Pharmacol. 2008, 76:289-302.
496. Lenaz G., Fato R., Formiggini G., Genova M.L. The role of coenzyme Q in mitochondrial electron transport. Mitochondrion 2007, 7S:S8-S33.
497. Littarru G.P., Langsjoen P. Coenzyme Q10 and statins: Biochemical and clinical implications. Mitochondrion 2007, 7S:S168-S174.
498. 10: An update. Nutrition 2010, 26:250-254.
499. López-Lluch G., Rodríguez-Aguilera J.C., Santos-Ocana C., Navas P. Is coenzyme Q a key factor in aging?. Mech. Ageing Dev. 2010, 131:225-235.
500. Miles M.V. The uptake and distribution of coenzyme Q(10). Mitochondrion 2007, 7S:S72-S77.
501. 10 in cardiovascular disease. Mitochondrion 2007, 7S:S154-S167.
502. Quinzil C.M., Hirano M. Coenzyme Q and mitochondrial disease. Dev. Disabil. Res. Rev. 2010, 16:183-188.
503. Allen L.H. New approaches for designing and evaluating food fortification programs. J. Nutr. 2006, 136:1055-1058.
504. Guidelines on Food Fortification with Micronutrients 2006, FAO/WHO, Geneva, p. 376. L. Allen, F. de Benoist, O. Dary, R. Hurrell (Eds.).
505. Backstrand J.R. The history and future of food fortification in the United States: A public health perspective. Nutr. Rev. 2002, 60:15-26.
506. Food and Nutrition Board Dietary Reference Intakes: Applications in Dietary Planning 2003, National Academy Press, Washington, DC, p. 237.
507. Food and Nutrition Board Dietary Reference Intakes: Guiding Principles for Nutrition Labeling and Fortification 2003, National Academy Press, Washington, DC, p. 205.
508. Hiza, H.A.B., Bente, L., Fungwe, T., 2008. Nutrient Content of the US Food Supply, 2008. USDA Home Economics Report No. 58, p. 72.
509. Holden J.M., Harnly J.M., Beecher G.R. Food composition. Present Knowledge in Nutrition 2006, 781-794. International Life Science Institute - Nutritional Foundation, Washington, DC. B.A. Bowman, R.M. Russell (Eds.).
510. Mozafar A. Plant Vitamins: Agronomic, Physiological and Nutritional Aspects 1994, CRC Press, New York, NY, p. 43.
511. Ottaway P.B. The Technology of Vitamins in Foods 1993, Chapman & Hall, London.
512. Park Y.K., Sempos C.T., Barton C.N., et al. Effectiveness of food fortification in the United States: The case of pellagra. Am. J. Pub. Health 2000, 90:727-738.
513. Nutrition Labeling: Issues and Directions for the 1990s 1990, National Academy Press, Washington, DC, p. 325. D.V. Porter, R.O. Earle (Eds.).
514. Yates A.A. Which dietary reference intake is best suited to serve as the basis for nutrition labeling for daily values?. J. Nutr. 2006, 136:2457-2462.
515. Briefel R.R. Nutrition monitoring in the United States. Present Knowledge in Nutrition 2006, 838-858. ILSI Press, Washington, DC. ninth ed. B.A. Bowman, R.M. Russell (Eds.).
516. Combs G.F., Welch R.M., Duxbury J.M., et al. Food-Based Approaches to Preventing Micronutrient Malnutrition: An International Research Agenda 1996, Cornell University, Ithaca, NY, p. 68.
517. Dwyer J.T. Nutritional consequences of vegetarianism. Annu. Rev. Nutr. 1991, 11:61-91.
518. Gary P.J., Koehler K.M. Problems in interpretation of dietary and biochemical data from population studies. Present Knowledge in Nutrition 1990, 407-414. International Life Science Institute - Nutritional Foundation, Washington, DC. sixth ed. M. Brown (Ed.).
519. Gibson R.S. Principles of Nutritional Assessment 1990, Oxford University Press, New York, NY, p. 691.
520. Henríque-Sánchez P., Sánchez-Villegas A., Doreste-Alonso J., et al. Dietary assessment methods for micronutrient intake: A systematic review on vitamins. Br. J. Nutr. 2009, 102:S10-S37.
521. Interdepartmental Committee on Nutrition for National Defense Manual for Nutrition Surveys 1963, US Government Printing Office, Washington, DC, p. 327. second ed.
522. Pelletier D.L., Olson C.L., Frongillo E.A. Food insecurity, hunger and undernutrition. Present Knowledge in Nutrition 2006, 906-922. ILSI Press, Washington, DC. ninth ed. B.A. Bowman, R.M. Russell (Eds.).
523. Román-Vinas B., Serra-Majem L., Ribas-Barba L., et al. Overview of methods used to evaluate the adequacy of nutrient intakes for individuals and populations. Br. J. Nutr. 2009, 101(Suppl. 2):S6-S11.
524. Sauberlich H.E. Laboratory Tests for the Assessment of Nutritional Status 1999, CRC Press, Cleveland, OH, p. 486. second ed.
525. Beaton G.H. When is an individual an individual vs. a member of a group? An issue in application of the dietary reference intakes. Nutr. Rev. 2005, 64:211-225.
526. Chan L.N. Drug-nutrient interactions. Modern Nutrition in Health and Disease 2006, 1539-1553. Lippincott, New York, NY. tenth ed. M.E. Shils, M. Shike, B. Caballero, R. Cousins (Eds.).
527. Dwyer J.T. Dietary guidelines 2010. Nutr. Today 2010, 45:144-153.
528. Food and Nutrition Board Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D and Fluoride 1997, National Academy Press, Washington, DC, p. 432.
529. 12, Pantothenic Acid, Biotin and Choline 2000, National Academy Press, Washington, DC, p. 564.
530. Food and Nutrition Board Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium and Carotenoids 2000, National Academy Press, Washington, DC, p. 506.
531. Food and Nutrition Board Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium and Zinc 2001, National Academy Press, Washington, DC, p. 773.
532. Food and Nutrition Board Dietary Reference Intakes: Applications in Dietary Planning 2003, National Academy Press, Washington, DC, p. 237.
533. Food and Nutrition Board Dietary Reference Intakes: Guiding Principles for Nutrition Labeling and Fortification 2003, National Academy Press, Washington, DC, p. 205.
534. Food and Nutrition Board Dietary Reference Intakes, Calcium, Vitamin D 2010, National Academy Press, Washington, DC, p. 1115.
535. Joint WHO/FAO Expert Consultation Human Vitamin and Mineral Requirements 2001, Food and Agricultural Organisation, Rome, p. 286.
536. Joint WHO/FAO Consultation Diet, Nutrition and the Prevention of Chronic Diseases 2002, World Health Organisation, Geneva, p. 149.
537. Joost H.G., Gibney M.J., Cashman K.D., et al. Personalized nutrition: Status and perspectives. Br. J. Nutr. 2007, 98:26-31.
538. King J.C. An evidence-based approach for establishing dietary guidelines. J. Nutr. 2007, 137:480-483.
539. Mattys C., Bucchini L., Busstra M.C., et al. Dietary standards in the United States. Present Knowledge in Nutrition 2006, vol. II:859-875. ILSI, Washington, DC. ninth ed.
540. Murphy S. The recommended dietary allowance (RDA) should not be abandoned: An individual is both an individual and a member of a group. Nutr. Rev. 2006, 64:313-318.
541. Rosenberg I.H. Challenges and opportunities in the translation of the science of vitamins. Am. J. Clin. Nutr. 2007, 85(Suppl):325S-327S.
542. Russell R.M. Current framework for DRI development: What are the pros and cons?. Nutr. Rev. 2008, 66:455-458.
543. Taylor C.L., Albert J., Weisell R., Nishida C. International dietary standards: FAO and WHO. Present Knowledge in Nutrition 2006, vol. II:876-887. ILSI, Washington, DC. ninth ed.
544. Trumbo P. Challenges with using chronic disease endpoints in setting dietary reference intakes. Nutr. Rev. 2008, 66:459-464.
545. Functions of Vitamins Beyond Recommended Daily Allowances 2001, Karger, Basel, p. 214. P. Walter, D.H. Hornig, U. Moser (Eds.).
546. Yates A.A. Dietary reference intakes: Rationale and applications. Modern Nutrition in Health and Disease 2006, 1655-1672. Lippincott, New York, NY. tenth ed. M.E. Shils, M. Shike, B. Caballero, R. Cousins (Eds.).
547. Food and Nutrition Board Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D and Fluoride 1997, National Academy Press, Washington, DC, p. 432.
548. Food and Nutrition Board Dietary Reference Intakes: A Risk Assessment Model for Establishing Upper Intake Levels for Nutrients 1998, National Academy Press, Washington, DC, p. 71.
549. 12, Pantothenic Acid, Biotin and Choline 2000, National Academy Press, Washington, DC, p. 564.
550. Food and Nutrition Board Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium and Carotenoids 2000, National Academy Press, Washington, DC, p. 506.
551. Food and Nutrition Board Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium and Zinc 2001, National Academy Press, Washington, DC, p. 773.
552. Food and Nutrition Board Dietary Reference Intakes, Calcium, Vitamin D 2010, National Academy Press, Washington, DC, p. 1115.
553. Hathcock J.N. Vitamins and minerals: Efficacy and safety. Am. J. Clin. Nutr 1997, 66:427-437.
554. Joint WHO/FAO Consultation Diet, Nutrition and the Prevention of Chronic Diseases 2002, World Health Organisation, Geneva, p. 149.
555. Joint WHO/FAO Expert Consultation Human Vitamin and Mineral Requirements 2001, Food and Agricultural Organisation, Rome, p. 286.
556. Mason P. One is okay, more is better? Pharmacological aspects and safe limits of nutritional supplements. Proc. Nutr. Soc 2007, 66:493-507.
557. Subcommittee on Vitamin Tolerance, Committee on Animal Nutrition, National Research Council Vitamin Tolerance in Animals 1987, National Academy Press, Washington, DC.